Abstract
Purpose
This study was designed to detect the prevalence of poor sleep quality in cervical cancer patients before and after adjuvant therapy, determine whether the prevalence of poor sleep quality in cervical cancer patients is higher than that in the general population, and analyze the factors associated with poor sleep quality.
Methods
A total of 76 stages I and II cervical cancer patients and 116 female residents completed the Pittsburgh Sleep Quality Index (PSQI). Patient Neurotoxicity Questionnaire (PNQ), Distress Thermometer (DT), Multidimensional Fatigue Inventory, and Hospital Anxiety and Depression Scale were used to measure the patients’ chemotherapy-induced peripheral neurotoxicity (CIPN), psychological distress, fatigue, anxiety, and depression. Data on social support and exercise were collected by the questionnaire. Logistic regression was used to identify the factors associated with poor sleep quality.
Results
Prevalence rates of poor sleep quality were 27.59 % for female residents, 52.63 % for patients before adjuvant therapy, and 64.50 % for patients after adjuvant therapy. The distributions of the PSQI scores of the patients before (Z = 3.814, P < 0.001) and after (Z = 5.957, P < 0.001) adjuvant therapy were different from those of the residents. The difference in the PSQI scores before and after adjuvant therapy among cervical cancer patients was significant (P = 0.007). The factors associated with poor sleep quality were high DT score (P = 0.045), depression (P = 0.028), anxiety (P = 0.027), high PNQ grade (P = 0.016), and chemotherapy + radiotherapy treatment (P = 0.017). Exercise was a protective factor for poor sleep quality (P =0.019).
Conclusion
The prevalence of poor sleep quality in stages I and II cervical cancer patients was approximately twice than that of women in the communities. Cancer treatment considerably affected sleep quality. Psychological distress, depression, anxiety, and high grade of CIPN during adjuvant therapy were factors associated with poor sleep quality. Exercise during adjuvant therapy could reduce the risk of poor sleep quality.
Similar content being viewed by others
References
China Cancer Database: The epidemiology of cervical cancer: http://cancernet.cicams.ac.cn
Chinese Center For Disease Control And Prevention: http://www.chinacdc.net.cn
Ministry of Health of the People’s Republic of China. http://wsb.moh.gov.cn/mohylfwjgs/s3581/201304/03083e543090484787f91e8f81b281c3.shtml
Hong JS, Tian J (2014) Prevalence of anxiety and depression and their risk factors in Chinese cancer patients. Support Care Cancer 22:453–459
Shuman AG, Duffy SA, Ronis DL et al (2010) Predictors of poor sleep quality among head and neck cancer patients. Laryngoscope 120:1166–1172
Dahiya S, Ahluwalia MS, Walia HK (2013) Sleep disturbances in cancer patients: underrecognized and undertreated. Cleve Clin J Med 80:722–732
Mercadante S, Gireli D, Casuccio A (2004) Sleep disorders in advanced cancer patients: prevalence and factors associated. Support Care Cancer 12:355–359
Mullington J, Haack M, Toth M, Serrado J, Meier-Ewert H (2009) Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Card Dis 51(4):294–302
Ancoli-Israel S, Moore PJ, Jones V (2001) The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care 10(4):245–255
Graci G (2005) Managing sleep disorders in cancer patients. J Support Oncol 3(5):349–359
Davidson JR, Maclean AW, Brundage MD, Schulze K (2002) Sleep disturbance in cancer patients. Soc Sci Med 54:1309–1321
Zarogoulidis P, Steiropoulos P, Perantoni E et al (2013) Subjective sleep quality in lung cancer patients before and after chemotherapy. Thorac Cancer 4:138–142
Delsigne J (2013) Managing sleep disorders in cancer patients. Oncology 58(2):4–5
Theobald ED (2004) Cancer pain, fatigue, distress, and insomnia in cancer patients. Clin Cornerstone 6:15–21
Lianqi L (2008) Sleep disturbances in cancer. Psychıatr Ann 38:627–634
Torkzahrani S, Rastegari L, Khodakarami N et al (2013) Quality of life and its related factors among Iranian cervical cancer survivors. Iran Red Crescent Med J 15(4):320–323
Lin LY, Wu JH, Yang CW, Sheu BC, Lin HH (2004) Impact of radical hysterectomy for cervical cancer on urodynamic findings. Int Urogynecol J 4(15):418–421
Lutgendorf SK, Anderson B, Ullrich P et al (2002) Quality of life and mood in women with gynecologic cancer: a one year prospective study. Cancer 94(1):131–140
Burns M, Costello J, Ryan-Woolley B, Davidson S (2007) Assessing the impact of late treatment effects in cervical cancer: an exploratory study of women’s sexuality. Eur J Cancer Care 16:364–372
Costanzo ES, Lutgendorf SK, Rothrock NE, Anderson B (2006) Coping and quality of life among women extensively treated for gynecologic cancer. Psychooncology 15:132–142
Markman M (1996) Chemotherapy-associated neurotoxicity: an important side-effect impacting on quality, rather than quantity of life. J Cancer Res Clin Oncol 122:511–512
Lee K, Cho M, Miaskowiski C, Dodd M (2004) Impaired sleep and rhythms in persons with cancer. Sleep Med Rev 8(3):199–212
Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213
Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F (2006) Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 33(1):15–49
Kuroi K, Shimozuma K, Ohashi Y et al (2008) A questionnaire survey of physicians’ perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer. Jpn J Clin Oncol 38(11):748–754
Shimozuma K, Ohashi Y, Takeuchi A et al (2009) Feasibility and validity of the Patient Neurotoxicity Questionnaire (PNQ) during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02. Support Care Cancer 17(12):1483–1491
National Comprehensive Cancer Network (2003) Distress management clinical practice guidelines. J Natl Compr Canc Netw 1(3):344–374
Hawkes AL, Hughes KL, Hutchison SD, Chambers SK (2010) Feasibility of brief psychological distress screening by a community-based telephone helpline for cancer patients and carers. BMC Cancer 10:1–10
Patel D, Sharpe L, Thewes B, Bell ML, Clarke S (2011) Using the Distress Thermometer and Hospital Anxiety and Depression Scale to screen for psychosocial morbidity in patients diagnosed with colorectal cancer. J Affect Disord 131:412–416
Tang L-I, Zhang Y-N, Pang Y et al (2005) Validation and reliability of Distress Thermometer in Chinese cancer patients. Chin J Cancer Res 23:54–58
Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370
Leung CM, Ho S, Kan CS, Hung CH, Chen CN (1993) Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale. Across-cultural perspective. Int J Psychosom 40:29–34
Smets EM, Garssen B, Bonke B, De Haes JC (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325
Tian J, Hong JS (2011) Validation of the Chinese version of Multidimensional Fatigue Inventory-20 in Chinese patients with cancer. Support Care Cancer 20:2379–2383
Wang XD, Wang XL, Ma Hong (1999) Rating scales for mental health. Zhongguo xingli Weisheng Zazhi Press
Xie J, Wu AQ (2003) Assessments of the Life Event Scale and Social Support Questionnaire for the patients with generalized anxiety disorder and panic attack. Suzhou Univ J Med Sci 23(2):220–223 (In Chinese)
Ye YM, Dai XY (2008) Development of social support scale for university students. Chin J Clin Psychol 16(5):456–458 (In Chinese)
Cui H, Hu JS, Lang SY et al (2010) Revision of Social Support Scale for Chinese military personnel. Chin J Clin Psychol 18(5):565–567 (In Chinese)
Xiao SY (1994) Theoretical fundamentals and applications of Chinese Social Support Questionnaire. J Clin Psychol Med 4(2):98–100 (In Chinese)
Liu JW, Li FY, Lian YL et al (2008) Investigation of reliability and validity of the social support scale. J Xinjiang Med Univ 31(1):1–3 (In Chinese)
Anderson KO, Getto CJ, Mendoza TR et al (2003) Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manag 25:307–318
Savard J, Laroche L, Simard S, Ivers H, Morin CM (2003) Chronic insomnia and immune functioning. Psychosom Med 65:211–221
Owen DC, Parker KP, McGuire DB (1999) Comparison of subjective sleep quality in patients with cancer and healthy subjects. Oncol Nurs Forum 26:1649–1651
Engstrom CA, Strohl RA, Rose L, Lewandowski L, Stefanek ME (1999) Sleep alterations in cancer patients. Cancer Nurs 22(2):143–148
O’Donnell JF. Insomnia in cancer patients (2004) Clin Cornerstone 6 suppl 1D:S6-S14
Sateia MJ, Lang BJ (2008) Sleep and cancer: recent developments. Curr Oncol Rep 10:309–318
Savard J, Simard S, Hervouet S et al (2005) Insomnia in men treated with radical prostatectomy for prostate cancer. Psychooncology 14(2):147–156
Savard J, Liu L, Natarajan L, Rissling MB et al (2009) Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep 32(9):1155–1160
Furlani R, Ceolim MF (2006) Sleep quality of women with gynecological and breast cancer. Rev Latino-Am Enfermagem 14(6):872–878
Polomano RC, Bennett GJ (2001) Chemotherapy-evoked painful peripheral neuropathy. Pain Med 2(1):8–14
Bakitas MA (2007) Background noise: the experience of chemotherapy-induced peripheral neuropathy. Nurs Res 56(5):323–331
Tofthagen C, Donovan KA, Morgan MA et al (2013) Oxaliplatin-induced peripheral neuropathy’s effects on health-related quality of life of colorectal cancer survivors. Support Care Cancer. doi:10.1007/s00520-013-1905-5
Cimprich B (1999) Pretreatment symptom distress in women newly diagnosed with breast cancer. Cancer Nurs 22:185–194
Clevenger L, Schrepf A, Degeest K et al (2013) Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis. Cancer 119(17):3234–3241
Bardwell WA, Profant J, Casden DR et al (2008) The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psychooncology 17:9–18
Carlson LE, Campbell TS, Garland SN, Grossman P (2007) Associations among salivary cortisol, melatonin, catecholamines, sleep quality and stress in women with breast cancer and healthy controls. J Behav Med 30:45–48
Palesh OG, Collie K, Batiuchok D et al (2006) A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol 75:37–44
Driver HS, Taylor SR (2000) Exercise and sleep. Sleep Med Rev 4(4):387–402
Payne C, Larkin PJ, McIlfatrick S, Dunwoody L, Gracey JH (2013) Exercise and nutrition interventions in advanced lung cancer: a systematic review. Curr Oncol 20:e321–e337
Payne JK, Held J, Thorpe J, Shaw H (2008) Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. Oncol Nurs Forum 35(4):635–642
Mock V, Dow KH, Meares CJ et al (1997) Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 24(6):991–1000
Wang YJ, Boehmke M, Wu YW, Dickerson SS, Fisher N (2011) Effects of a 6-week walking program on Taiwanese women newly diagnosed with early-stage breast cancer. Cancer Nurs 34(2):E1–E13
Tang MF, Liou TH, Lin CC (2010) Improving sleep quality for cancer patients: benefits of a home-based exercise intervention. Support Care Cancer 18(10):1329–1339
Mustian KM, Sprod LK, Palesh OG et al (2009) Exercise for the management of side effects and quality of life among cancer survivors. Curr Sports Med Rep 8(6):325–330
Conflict of interest
No conflicts of interest to declare. This study has no financial relationship with any organization that sponsored the research and authorship. The corresponding author has full control of all primary data and will allow the journal to review our data if requested.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tian, J., Chen, G.L. & Zhang, H.R. Sleep status of cervical cancer patients and predictors of poor sleep quality during adjuvant therapy. Support Care Cancer 23, 1401–1408 (2015). https://doi.org/10.1007/s00520-014-2493-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-014-2493-8